Boosting experience-dependent neuroplasticity in adult brains

brain
Credit: Wikimedia Commons
(Medical Xpress)—Experience-dependent neuroplasticity refers to the brain's capacity to change in response to experience, repeated stimuli, environmental cues, and learning. It's a fundamental property of brain function, and researchers note that its impairment is a feature of many neurological and psychiatric disorders including depression, bipolar disorder and schizophrenia. Improving impaired plasticity is thus a subject of interest for psychological researchers.

In a recent study published in the Proceedings of the National Academy of Sciences, a group of researchers from various U.S. colleges have collaborated to determine if augmenting the signaling of a particular brain receptor would boost in adults. During early development, experience-dependent neuroplasticity actually interacts with genetic programming in order to establish the neuronal organization and functionally connected circuits that characterize the mature brain.

This basic circuitry is well established by early adulthood, but throughout the lifespan, depend on experience-dependent neuroplasticity to enable new behavior patterns. Given the general acceptance of the relatively new idea that neuroplasticity endures in adults, the ability to augment its mechanisms could yield new approaches to associated psychiatric disorders. Here, the researchers sought to determine if augmenting N-methyl-D-aspartate receptor (NMDAR) signaling would promote experience-dependent plasticity. They tested a drug called D-cycloserine (DCS) on a group of participants who were monitored via a recently developed EEG paradigm for changes in plasticity.

The participants, divided into groups that received either DCS or placebo, engaged in three cognitive tasks: A weather prediction task, an information integration task and an n-back task, once before administration of DCS or placebo, and again 31 hours later. They determined that participants who received DCS showed greater potentiation of plasticity following the high-frequency visual stimuli of the tests than did those who received placebo. "Our findings of enhanced acquisition of the weather prediction task and the information integration task are consistent with other findings of enhanced incremental learning following DCS administration, including on category learning, motor learning, and mental rotation learning tasks," the authors write.

They note that the performance of DCS participants on the n-back test, which was a spatial task, did not differ measurably from the performance of those receiving placebo. They note that this result is consistent with a growing body of evidence that the transient memory underlying working memory is modulated in a fundamentally different way than experience-dependent neuroplasticity.

While noting the limitation that the study was restricted to healthy young adults, the authors conclude that their results strongly suggest that enhancing NMDAR signaling augments experience-dependent plasticity in adult brains across a variety of tasks that leverage that ability. "These findings suggest exciting possibilities for using NMDAR agonists to help ameliorate plasticity deficits in neurodegenerative and psychiatric disorders. Our results complement a growing literature that suggests that DCS can enhance new learning during cognitive behavioral therapy interventions and cognitive training programs."

The researchers suggest that parallel studies in older adults and patient groups are an obligatory next step in assessing DCS as a therapeutic intervention for .


Explore further

PTSD psychotherapy is enhanced with D-cycloserine

More information: Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain. PNAS 2015 ; published ahead of print November 30, 2015, DOI: 10.1073/pnas.1509262112

Abstract
Experience-dependent plasticity is a fundamental property of the brain. It is critical for everyday function, is impaired in a range of neurological and psychiatric disorders, and frequently depends on long-term potentiation (LTP). Preclinical studies suggest that augmenting N-methyl-D-aspartate receptor (NMDAR) signaling may promote experience-dependent plasticity; however, a lack of noninvasive methods has limited our ability to test this idea in humans until recently. We examined the effects of enhancing NMDAR signaling using D-cycloserine (DCS) on a recently developed LTP EEG paradigm that uses high-frequency visual stimulation (HFvS) to induce neural potentiation in visual cortex neurons, as well as on three cognitive tasks: a weather prediction task (WPT), an information integration task (IIT), and a n-back task. The WPT and IIT are learning tasks that require practice with feedback to reach optimal performance. The n-back assesses working memory. Healthy adults were randomized to receive DCS (100 mg; n = 32) or placebo (n = 33); groups were similar in IQ and demographic characteristics. Participants who received DCS showed enhanced potentiation of neural responses following repetitive HFvS, as well as enhanced performance on the WPT and IIT. Groups did not differ on the n-back. Augmenting NMDAR signaling using DCS therefore enhanced activity-dependent plasticity in human adults, as demonstrated by lasting enhancement of neural potentiation following repetitive HFvS and accelerated acquisition of two learning tasks. Results highlight the utility of considering cellular mechanisms underlying distinct cognitive functions when investigating potential cognitive enhancers.

© 2015 Medical Xpress

Citation: Boosting experience-dependent neuroplasticity in adult brains (2015, December 8) retrieved 24 June 2019 from https://medicalxpress.com/news/2015-12-boosting-experience-dependent-neuroplasticity-adult-brains.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
250 shares

Feedback to editors

User comments

Dec 08, 2015
Hello study drug...

Dec 11, 2015
Augmenting NMDAr and/or AMPAr is extremely dangerous due to risk of prolonged excitotoxicity, resulting in neuroinflammation and cell death. I myself am a victim. NMDAr agonists are a dime a dozen. The maximum I can safely recommend in good conscience is calcium and glycine. A far safer approach is dopaminergic agonism while exposing the subject to the new stimuli; the NMDAr and AMPAr will then adjust automatically. A final note is that a drug like memantine is special in that it will agonize weak NMDAr signals while antagonizing strong (dangerous) NMDAr signals.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more